Cited by 8,029Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Open access

The SOLVD Investigators*·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250501

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. METHODS: Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-bind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. RESULTS: There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P less than 0.0001). CONCLUSIONS: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250501

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A. N., Devereux, R. B., Feigenbaum, H., Gutgesell, H. P., Reichek, N., Sahn, D. J., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,110
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386

Show all 15 references

Research works printed but not linked: 1

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

Sorted by citations

Items 701–800 of 1,027

Gq Signaling in Cardiac Adaptation and Maladaptation
Dorn, G. W. (1999) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(99)00004-3 · Cited by 169
Cardiotoxicity of Cancer Chemotherapy
Simbre, V. C., Duffy, S. A., Dadlani, G. H., Miller, T. L., & Lipshultz, S. E. (2005) · Pediatric Drugs · doi:10.2165/00148581-200507030-00005 · Cited by 168
Oxidative Stress and Lectin-Like Ox-LDL-Receptor LOX-1 in Atherogenesis and Tumorigenesis
Lü, J., Mitra, S., Wang, X., Khaidakov, M., & Mehta, J. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3792 · Cited by 168
Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease
Ananthapanyasut, W., Napan, S., Rudolph, E. H., Harindhanavudhi, T., Ayash, H., Guglielmi, K. E., & Lerma, E. V. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03170509 · Cited by 168
New Therapeutic Options in Congestive Heart Failure: Part I
McMurray, J. J. V., & Pfeffer, M. A. (2002) · Circulation · doi:10.1161/01.cir.0000014763.63528.9d · Cited by 168
Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling.
Johnston, C. I. (1994) · Hypertension · doi:10.1161/01.hyp.23.2.258 · Cited by 168
Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006
Krum, H., Jelinek, M. V., Stewart, S., Sindone, A. P., Atherton, J. J., & Hawkes, A. L. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00690.x · Cited by 167
Cardiac MRI in the Assessment of Cardiac Injury and Toxicity From Cancer Chemotherapy
Thavendiranathan, P., Wintersperger, B. J., Flamm, S. D., & Marwick, T. H. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.000899 · Cited by 167
Altered proximal tubular cell glucose metabolism during acute kidney injury is associated with mortality
Legouis, D., Ricksten, S.-E., Faivre, A., Verissimo, T., Gariani, K., Verney, C., Galichon, P., Berchtold, L., Féraille, E., Fernandez, M., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0238-1 · Cited by 167
Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: Results from the Studies of Left Ventricular Dysfunction (SOLVD)
Knight, E. L., Glynn, R. J., McIntyre, K. M., Mogun, H., & Avorn, J. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70009-8 · Cited by 167
Pharmacotherapy for Heart Failure in Patients with Renal Insufficiency
Shlipak, M. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00013 · Cited by 167
Ischemic stroke after heart failure: A community-based study
Witt, B. J., Brown, R. D., Jacobsen, S. J., Weston, S. A., Ballman, K. V., Meverden, R. A., & Roger, V. L. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.018 · Cited by 166
Framingham Study Insights into Hypertensive Risk of Cardiovascular Disease.
Kannel, W. B. (1995) · Hypertension Research · doi:10.1291/hypres.18.181 · Cited by 166
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
Heck, S. L., Mecinaj, A., Ree, A. H., Hoffmann, P., Schulz‐Menger, J., Fagerland, M. W., Gravdehaug, B., Røsjø, H. R., Steine, K., Geisler, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.054698 · Cited by 166
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Tsutsui, H., Ide, T., Ito, H., Kihara, Y., Kinugawa, K., Kinugawa, S., Makaya, M., Murohara, T., Node, K., Saito, Y., et al. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.04.023 · Cited by 166
Heart failure
Krum, H., & Abraham, W. T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60236-1 · Cited by 166
Frailty and heart failure: State‐of‐the‐art review
Talha, K. M., Pandey, A., Fudim, M., Butler, J., Anker, S. D., & Khan, M. S. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13306 · Cited by 166
Toward the quiescent coronary plaque
MacIsaac, A. I., Thomas, J. A. M. D., & Topol, E. J. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90442-4 · Cited by 166
Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials
Tacon, C. L., McCaffrey, J., & Delaney, A. P. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2435-6 · Cited by 165
Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
Molnar, M. Z., Kalantar‐Zadeh, K., Lott, E. H., Lü, J., Malakauskas, S. M., Ma, J. Z., Quarles, L. D., & Kovesdy, C. P. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.050 · Cited by 165
Diuretics for heart failure
Faris, R. F., Flather, M. D., Purcell, H., Poole-Wilson, P. A., & Coats, A. J. S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003838.pub3 · Cited by 165
Retracted
Cardiomyopathy, familial dilated
Taylor, M. R. G., Carniel, E., & Mestroni, L. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-27 · Cited by 164
Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria
Vaur, L., Gueret, P., Lievre, M., Chabaud, S., Passa, P., & For the DIABHYCAR Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.855 · Cited by 163
Detecting Selection Bias in Randomized Clinical Trials
Berger, V. W., & Exner, D. V. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00014-8 · Cited by 163
Renin-Angiotensin System Components in the Interstitial Fluid of the Isolated Perfused Rat Heart
de Lannoy, L. M., Danser, A. H. J., van Kats, J. P., Schoemaker, R. G., Saxena, P. R., & Schalekamp, M. A. D. H. (1997) · Hypertension · doi:10.1161/01.hyp.29.6.1240 · Cited by 163
Diabetic cardiomyopathy
Asghar, O., Alsunni, A. A., Khavandi, K., Khavandi, A., Withers, S., Greenstein, A. S., Heagerty, A. M., & Malik, R. A. (2009) · Clinical Science · doi:10.1042/cs20080500 · Cited by 162
Cardiovascular organ-on-a-chip platforms for drug discovery and development
Ribas, J., Sadeghi, H., Manbachi, A., Leijten, J., Brinegar, K., Zhang, Y. S., Ferreira, L., & Khademhosseini, A. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0002 · Cited by 161
Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function
Al-Mallah, M. H., Tleyjeh, I. M., Abdel‐Latif, A., & Weaver, W. D. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.073 · Cited by 161
Epidemiological trends in invasive mechanical ventilation in the United States: A population-based study
Mehta, A., Syeda, S. N., Wiener, R. S., & Walkey, A. J. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.07.007 · Cited by 161
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials
Kent, D. M., Nelson, J., Dahabreh, I. J., Rothwell, P. M., Altman, D. G., & Hayward, R. A. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw118 · Cited by 161
The health care costs of heart failure in Sweden
Rydén‐Bergsten, T., & Andersson, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00520.x · Cited by 161
Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease Possible role for left ventricular remodelling
Kameda, K. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.022 · Cited by 161
Demographics and concomitant disorders in heart failure
Krum, H., & Gilbert, R. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13869-x · Cited by 161
Angiotensin–converting enzyme (ACE) inhibitors and angio–oedema
Sabroe, R. A., & BLACK, A. K. (1997) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1997.tb14887.x · Cited by 161
Angiotensin-converting enzyme inhibitor-associated angioedema
Byrd, J. B., Adam, A., & Brown, N. J. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.08.001 · Cited by 160
Evidence for altered interleukin (IL)‐18 pathway in human heart failure
Mallat, Z., Heymes, C., Corbaz, A., Logeart, D., Alouani, S., Solal, A. C., Seidler, T., Hasenfuss, G. P., Chvatchko, Y., Shah, A. M., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2426fje · Cited by 160
Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy
Gatzoulis, K. A., ANDRIKOPOULOS, G., Apostolopoulos, T., Sotiropoulos, E., Zervopoulos, G., Antoniou, J. D., Brili, S., & Stefanadis, C. (2005) · EP Europace · doi:10.1016/j.eupc.2005.01.003 · Cited by 160
Evaluating Quality of Care for Patients With Heart Failure
Krumholz, H. M., Baker, D. W., Ashton, C. M., Dunbar, S. B., Friesinger, G. C., Havranek, E. P., Hlatky, M. A., Konstam, M. A., Ordin, D. L., Piña, I. L., et al. (2000) · Circulation · doi:10.1161/01.cir.101.12.e122 · Cited by 160
Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure
Yee, K.-M., Pringle, S. D., & Struthers, A. D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01243-8 · Cited by 160
Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality
Kittleson, M. M., Hurwitz, S., Shah, M., Nohria, A., Lewis, E. F., Givertz, M. M., Fang, J. C.-T., Jarcho, J. A., Mudge, G. H., & Stevenson, L. W. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00417-0 · Cited by 160
The burden of heart failure
McMurray, J. J. V., & Stewart, S. (2003) · European Heart Journal Supplements · doi:10.1016/s1520-765x(03)80002-0 · Cited by 159
Catabolism in chronic heart failure
Berry, C. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1882 · Cited by 159
Improvement in Exercise Tolerance and Symptoms of Congestive Heart Failure During Treatment With Candesartan Cilexetil
Riegger, G. A. J., Bouzo, H., Petr, P., Münz, J., Špaček, R., Pethig, H., von Behren, V., George, M., & Arens, H.-J. (1999) · Circulation · doi:10.1161/01.cir.100.22.2224 · Cited by 159
Heart failure in the 1990s: Evolutions of a major public health problem in cardiovascular medicine
Garg, R., Packer, M., Pitt, B., & Yusuf, S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90454-9 · Cited by 159
Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)
Kostis, J. B., Shelton, B. J., Gosselin, G., Goulet, C., Hood, W. B., Kohn, R. M., Kubo, S. H., SCHRON, E. B., Weiss, M. B., Willis, P. W., et al. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90365-8 · Cited by 158
Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction
Rogers, W. J., Johnstone, D. E., Yusuf, S., Weiner, D. H., Gallagher, P. N., Bittner, V., Ahn, S. A., SCHRON, E. B., Shumaker, S. A., & Sheffield, L. T. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90426-x · Cited by 158
Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy
Corrado, G., Lissoni, A., Beretta, S., Terenghi, L., Tadeo, G., Foglia-Manzillo, G., Tagliagambe, L. M., Spata, M., & Santarone, M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02195-1 · Cited by 157
B-type natriuretic peptide levels: A potential novel “white count” for congestive heart failure
Maisel, A. (2001) · Journal of Cardiac Failure · doi:10.1054/jcaf.2001.24609 · Cited by 157
The Incidence and Prevalence of Congestive Heart Failure in Rochester, Minnesota
Rodeheffer, R. J., Jacobsen, S. J., Gersh, B. J., Kottke, T. E., McCann, H. A., Bailey, K. R., & Ballard, D. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60063-9 · Cited by 157
The 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH Meeting
Zanchetti, A., Chalmers, J. P., Arakawa, K., Gyarfas, I., Hamet, P., Hansson, L., Julius, S., MacMahon, S. W., Mancia, G., Ménard, J., et al. (1993) · Blood Pressure · doi:10.3109/08037059309077535 · Cited by 157
LCZ696, An Angiotensin Receptor–Neprilysin Inhibitor, Improves Cardiac Function with the Attenuation of Fibrosis in Heart Failure with Reduced Ejection Fraction in Streptozotocin-Induced Diabetic Mice
Suematsu, Y., Miura, S., Goto, M., Matsuo, Y., Arimura, T., Kuwano, T., Imaizumi, S., Iwata, A., Yahiro, E., & Saku, K. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.474 · Cited by 156
Clinical definition and epidemiology of advanced heart failure
Adams, K. F., & Zannad, F. M. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70251-0 · Cited by 156
Angiotensin-converting enzyme inhibitors and the risk of cancer
Friis, S., Sørensen, H. T., Mellemkjøer, L., McLaughlin, J. K., Nielsen, G. L., Blot, W. J., & Olsen, J. H. (2001) · Cancer · doi:10.1002/1097-0142(20011101)92:9 · Cited by 156
Effects of renin-angiotensin system inhibition end-organ protection: Can we do better?
WEIR, M. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.019 · Cited by 156
The Natriuretic Peptides in Heart Failure: Diagnostic and Therapeutic Potentials
Chen, H. H., & Burnett, J. C. J. (1999) · Proceedings of the Association of American Physicians · doi:10.1111/paa.1999.111.5.406 · Cited by 156
National Patterns of Angiotensin-Converting Enzyme Inhibitor Use in Congestive Heart Failure
Stafford, R. S. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420092008 · Cited by 156
The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
Braunwald, E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.033 · Cited by 155
Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting?
Ngaage, D. L., Schaff, H. V., Mullany, C. J., Sundt, T. M., Dearani, J. A., Barnes, S. A., Daly, R. C., & Orszulak, T. A. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.09.021 · Cited by 155
Cardiac Resynchronization Therapy: Current State of the Art
Auricchio, A., & Abraham, W. T. (2004) · Circulation · doi:10.1161/01.cir.0000115583.20268.e1 · Cited by 155
The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial
The BENCH (BENazepril in Canine Heart disease) Study Group (1999) · Journal of Veterinary Cardiology · doi:10.1016/s1760-2734(06)70025-x · Cited by 155
Long-term outcome after primary angioplasty: report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) trial
Nunn, C. M., O’Neill, W. W., ROTHBAUM, D. A., Stone, G. W., O’Keefe, J. H., OVERLIE, P. A., Donohue, B. C., Grines, L. L., Browne, K. F., Vlietstra, R. E., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00622-6 · Cited by 155
Management of Heart Failure
Dracup, K. (1994) · JAMA · doi:10.1001/jama.1994.03520180066037 · Cited by 155
The Cardiorenal Syndrome: Lessons from the ADHERE Database and Treatment Options
Heywood, J. T. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-6129-4 · Cited by 154
Systematic review of economic burden of heart failure
Shafie, A. A., Tan, Y. P., & Ng, C. H. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9661-0 · Cited by 154
Cardiovascular Effects of Insulin-Like Growth Factor-1 and Growth Hormone in Chronic Left Ventricular Failure in the Rat
Duerr, R. L., McKirnan, M. D., Gim, R., CLARK, R. G., Chien, K. R., & Ross, J. (1996) · Circulation · doi:10.1161/01.cir.93.12.2188 · Cited by 154
The endothelin system and its potential as a therapeutic target in cardiovascular disease
Gray, G. A., & Webb, D. J. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00101-5 · Cited by 154
Cost-effectiveness Analysis in Clinical Practice
Rich, M. W., & Nease, R. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.15.1690 · Cited by 154
The Euro Heart Failure Survey of The EUROHEART Survey Programme: A Survey on the Quality of Care Among Patients with Heart Failure in Europe
Cleland, J. G. F., Swedberg, K. B., Solal, A. C., Cosín‐Aguilar, J., Dietz, R., Folláth, F., Gavazzi, A., Hobbs, R. F., Korewicki, J., Madeira, H. C., et al. (2000) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00081-7 · Cited by 153
Unrecognised ventricular dysfunction in COPD
Macchia, A., Moncalvo, J. J. R., Kleinert, M., Comignani, P. D., Gimeno, G. M., Arakaki, D., Laffaye, N., Fuselli, J. J., Massolin, H. P., Gambarte, J., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00044411 · Cited by 153
Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves
Levine, H. J., & Gaasch, W. H. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00288-4 · Cited by 153
Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure
Pieruzzi, F., Abassi, Z. A., & Keiser, H. R. (1995) · Circulation · doi:10.1161/01.cir.92.10.3105 · Cited by 153
Heart failure as a cause for hospitalization in chronic dialysis patients
Trespalacios, F. C., Taylor, A. J., Agodoa, L. Y. C., Bakris, G. L., & Abbott, K. C. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00359-7 · Cited by 153
The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure
Andersson, B., & Sylvén, C. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00098-8 · Cited by 153
Tailored Therapy to Hemodynamic Goals for Advanced Heart Failure
Stevenson, L. W. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00015-x · Cited by 153
Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.
Omland, T., Aakvaag, A., & Vik‐Mo, H. (1996) · Heart · doi:10.1136/hrt.76.3.232 · Cited by 153
Pressure Overload Induces Severe Hypertrophy in Mice Treated With Cyclosporine, an Inhibitor of Calcineurin
Ding, B., Price, R. L., Borg, T. K., Weinberg, E. O., Halloran, P. F., & Lorell, B. H. (1999) · Circulation Research · doi:10.1161/01.res.84.6.729 · Cited by 153
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
Backer, G. D., Ambrosio, G., Borch‐Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · PubMed · doi:10.1097/01.hjr.0000087913.96265.e2 · Cited by 153
Current treatment of adult Duchenne muscular dystrophy
Wagner, K. R., Lechtzin, N., & Judge, D. P. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.06.009 · Cited by 152
Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor
Heywood, J. T., Jermyn, R. A., Shavelle, D. M., Abraham, W. T., Bhimaraj, A., Bhatt, K. A., Sheikh, F., Eichhorn, E. J., Lamba, S., Bharmi, R., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026184 · Cited by 152
Hemodynamic Changes in Patients with Alagille's Syndrome During Orthotopic Liver Transplantation
Png, K., Veyckemans, F., Kock, M. D., Carlier, M., Sluysmans, T., Otte, J. B., Reding, R., de Cléty, S. C., Sokal, E. M., & Obbergh, L. J. V. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199911000-00011 · Cited by 152
Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction
Frazier‐Mills, C. G., Alexander, K. P., Newby, L. K., Anderson, S., Iverson, E. R., Packer, M., Cohn, J. N., Goldstein, S., & Douglas, P. S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.041 · Cited by 152
Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial
The DREAM Trial Investigators (2004) · Diabetologia · doi:10.1007/s00125-004-1485-5 · Cited by 152
Self-citation
Activation of neurohumoral systems in postinfarction left ventricular dysfunction
Rouleau, J. L., de Champlain, J., Klein, M. D., Bichet, D. G., Moyé, L. A., Packer, M., Dagenais, G. R., Sussex, B. A., Arnold, J. M. O., Sestier, F., et al. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90042-y · Cited by 152
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G. L., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C. S., et al. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.06.001 · Cited by 151
A Double‐Blind, Placebo‐Controlled, Dose‐Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension
Wells, T. G., Frame, V., Soffer, B. A., Shaw, W. C., Zhang, Z., Herrera, P., Shahinfar, S., & Enalapril Pediatric Hypertension Collaborative Study Group (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002401102786 · Cited by 151
Effects of Repeated Sauna Treatment on Ventricular Arrhythmias in Patients With Chronic Heart Failure
Kihara, T., Biro, S., Ikeda, Y., Fukudome, T., Shinsato, T., Masuda, A., Miyata, M., Hamasaki, S., Otsuji, Y., Minagoe, S., et al. (2004) · Circulation Journal · doi:10.1253/circj.68.1146 · Cited by 151
Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the studies of left ventricular dysfunctions (SOLVD) registry
Benedict, C. R., Weiner, D. H., Johnstone, D. E., Bourassa, M. G., Ghali, J. K., Nicklas, J. M., Kirlin, P. C., Greenberg, B., Quiñones, M. A., & Yusuf, S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90480-o · Cited by 151
Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction
King, J. B., Shah, R. U., Bress, A. P., Nelson, R. E., & Bellows, B. K. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.02.007 · Cited by 150
Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts
Burke, R. M., Lighthouse, J. K., Mickelsen, D. M., & Small, E. M. (2019) · Circulation Heart Failure · doi:10.1161/circheartfailure.118.005565 · Cited by 150
Failure of Women’s Hearts
Petrie, M. C., Dawson, N., Murdoch, D. R., Davie, A. P., & McMurray, J. J. V. (1999) · Circulation · doi:10.1161/01.cir.99.17.2334 · Cited by 150
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker, L. E., Noll, G., Ruschitzka, F. T., & Lüscher, T. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01210-4 · Cited by 150
Open access echocardiography in management of heart failure in the community
Francis, C. M., Caruana, L., Kearney, P. P., Love, M. P., Sutherland, G. R., Starkey, I. R., Shaw, T. R. D., & McMurray, J. J. V. (1995) · BMJ · doi:10.1136/bmj.310.6980.634 · Cited by 150
Secondary prevention with folic acid: effects on clinical outcomes
Liem, A. H., Reynierse-Buitenwerf, G. H., Zwinderman, A. H., Jukema, J. W., & van Veldhuisen, D. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00485-6 · Cited by 150
Novel RAAS agonists and antagonists: clinical applications and controversies
Romero, C. A., Orías, M., & Weir, M. R. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.6 · Cited by 148
Modulation of the Renin-Angiotensin Pathway Through Enzyme Inhibition and Specific Receptor Blockade in Pacing-Induced Heart Failure
Spinale, F. G., de Gasparo, M., Whitebread, S., Hebbar, L., Clair, M. J., Melton, D. M., Krombach, R. S., Mukherjee, R. D., Iannini, J. P., & Seung-Jun, O. (1997) · Circulation · doi:10.1161/01.cir.96.7.2385 · Cited by 148
Repolarization Abnormalities, Arrhythmia and Sudden Death in Canine Tachycardia-Induced Cardiomyopathy
Pak, P. H., Nuss, H. B., Tunin, R. S., Kääb, S., Tomaselli, G. F., Marbán, E., & Kass, D. A. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00193-9 · Cited by 148
Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association.
OʼConnell, J. B., Bourge, R. C., Costanzo-Nordin, M. R., Driscoll, D. J. O., Morgan, J. P., Rose, E. A., & Uretsky, B. F. (1992) · Circulation · doi:10.1161/01.cir.86.3.1061 · Cited by 148
ACE Inhibitors — A Cornerstone of the Treatment of Heart Failure
Braunwald, E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250508 · Cited by 148
Normal Left Ventricular Mechanics by Two-dimensional Speckle-tracking Echocardiography. Reference Values in Healthy Adults
Kocabay, G., Muraru, D., Peluso, D., Cucchini, U., Mihaila, S. B., Jose, S. P., Denas, G., Iliceto, S., Vinereanu, D., & Badano, L. P. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.12.009 · Cited by 147
Coronary blood flow in heart failure: cause, consequence and bystander
Heusch, G. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00909-8 · Cited by 147

Authors: The SOLVD Investigators*
Corresponding author: The SOLVD Investigators*
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 293-302
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250501
OpenAlex: W2585382523
Cited by: 8,029
References: 15
Citations by year: 2026: 78 · 2025: 89 · 2024: 117 · 2023: 152 · 2022: 174 · 2021: 167 · 2020: 182 · 2019: 174 · 2018: 174 · 2017: 187 · 2016: 211 · 2015: 208 · 2014: 165 · 2013: 168 · 2012: 231
FWCI: 170.62
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, ACE inhibitors, congestive heart failure, reduced left ventricular ejection fraction, mortality, hospitalization, heart failure progression, cardiac arrhythmias, NYHA functional class
MeSH terms: Blood Pressure, Cause of Death, Chronic Disease, Double-Blind Method, Electrolytes, Enalapril, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Kidney, Male, Middle Aged, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks